ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study
June 02, 2021BioVaxys Technology Corp. is pleased to announce that its bioproduction partner Bio Elpida of Lyon, France, has initiated construction of a new Good Manufacturing Practice clean room facility needed for producing clinical supply of BVX-0918A ... -
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day
April 21, 2021BioVaxys Technology Corp., the world leader in haptenized antigen vaccines for antiviral and cancers applications, announced today its sponsorship of this year's World Ovarian Cancer Day, a major initiative of the World Ovarian Cancer Coalition, an ...
Pharma Sources Insight January 2025
